SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-19-042549
Filing Date
2019-11-12
Accepted
2019-11-12 07:26:24
Documents
14
Period of Report
2019-11-12
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K acor-8k_20191112.htm   iXBRL 8-K 35566
2 EX-99.1 acor-ex991_34.htm EX-99.1 11953
3 GRAPHIC gsvrjsbajfrk000001.jpg GRAPHIC 4764
  Complete submission text file 0001564590-19-042549.txt   185031

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA acor-20191112.xsd EX-101.SCH 5960
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE acor-20191112_lab.xml EX-101.LAB 18732
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acor-20191112_pre.xml EX-101.PRE 11167
14 EXTRACTED XBRL INSTANCE DOCUMENT acor-8k_20191112_htm.xml XML 3416
Mailing Address 420 SAW MILL RIVER ROAD ARDSLEY NY 10502
Business Address 420 SAW MILL RIVER ROAD ARDSLEY NY 10502 914-347-4300
ACORDA THERAPEUTICS INC (Filer) CIK: 0001008848 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31938 | Film No.: 191206080
SIC: 2836 Biological Products, (No Diagnostic Substances)